Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen

Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen

Background: Breast cancer (BC) is a heterogeneous disease for which the commonly used chemotherapeutic agents primarily include the anthracyclines (doxorubicin, epirubicin), microtubule inhibitors (paclitaxel, docetaxel, eribulin), and alkylating agents (cyclophosphamide). While these drugs can be h...

Full description

Bibliographic Details
Main Authors: Sugandha Bhatia, Tony Blick, Cletus Pinto, Mark Waltham, James Monkman, Ekaterina Ivanova, Pamela M. Pollock, Shivashankar H. Nagaraj, Adrian P. Wiegmans, Izhak Haviv, Kaylene J. Simpson, Erik W. Thompson
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
chemotherapy resistance
combination chemotherapy
doxorubicin
docetaxel
eribulin
TGFBR
Online Access:https://www.mdpi.com/2072-6694/12/5/1123

Internet

https://www.mdpi.com/2072-6694/12/5/1123

Similar Items